Literature DB >> 11738258

Differential effects of alpha-, beta- and gamma(2)-melanocyte-stimulating hormones on hypothalamic neuronal activation and feeding in the fasted rat.

G W Millington1, Y C Tung, A K Hewson, S O'Rahilly, S L Dickson.   

Abstract

Hypothalamic pro-opiomelanocortin neurones have an established role in the control of feeding. While pro-opiomelanocortin is the precursor for at least three melanocortin peptides, alpha-, beta- and gamma-melanocyte-stimulating hormone (MSH), it has been widely assumed that alpha-MSH is the predominant ligand involved. We compared the effects of centrally administered alpha-, beta- and gamma(2)-MSH on hypothalamic neuronal activation and on food intake in rats fasted for 48 h. Significant reductions in food intake were seen with alpha-MSH (first hour) and gamma(2)-MSH (second hour) but not with beta-MSH. The pattern of neuronal activation, assessed by the detection of early growth response factor-1 protein, showed considerable overlap; all three melanocortins activated cells in the arcuate, ventromedial, paraventricular, periventricular and supraoptic nuclei, as well as the preoptic area. alpha-MSH and beta-MSH produced activation in the dorsomedial nuclei while gamma(2)-MSH was only weakly active here. Retrograde labelling by systemic Fluorogold injection revealed that many cells activated by MSH compounds in the arcuate, paraventricular, periventricular and supraoptic nuclei (but not dorsomedial or ventromedial) project outside the blood-brain barrier and are therefore likely to include neuroendocrine cells. Desacetyl-alpha-MSH, which has previously been reported to lack effects on feeding, produced no discernible neuronal activation in the hypothalamus. Our finding that both the pattern of neuronal activation and the distribution of neuroendocrine cells activated in response to these closely related peptides show only partial overlap suggests that, in addition to common pathways, there may exist distinct hypothalamic circuits activated by different pro-opiomelanocortin products. The slower time course of gamma(2)-MSH- versus alpha-MSH-induced suppression of feeding provides further support for the notion that the biological responses to individual melanocortin peptides may involve distinct neuronal mechanisms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738258     DOI: 10.1016/s0306-4522(01)00428-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  13 in total

Review 1.  GENETIC AND EPIGENETIC CAUSES OF OBESITY.

Authors:  Vidhu V Thaker
Journal:  Adolesc Med State Art Rev       Date:  2017

Review 2.  Bench-top to clinical therapies: A review of melanocortin ligands from 1954 to 2016.

Authors:  Mark D Ericson; Cody J Lensing; Katlyn A Fleming; Katherine N Schlasner; Skye R Doering; Carrie Haskell-Luevano
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-29       Impact factor: 5.187

Review 3.  POMC: The Physiological Power of Hormone Processing.

Authors:  Erika Harno; Thanuja Gali Ramamoorthy; Anthony P Coll; Anne White
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

4.  Deletion of prolyl carboxypeptidase attenuates the metabolic effects of diet-induced obesity.

Authors:  Jin Kwon Jeong; Gyorgyi Szabo; Giuseppina Mattace Raso; Rosaria Meli; Sabrina Diano
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-27       Impact factor: 4.310

5.  MR imaging presentation of intracranial disease associated with Langerhans cell histiocytosis.

Authors:  Daniela Prayer; Nicole Grois; Helmut Prosch; Helmut Gadner; Anthony J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

Review 6.  Melanocortin-4 receptor-regulated energy homeostasis.

Authors:  Michael J Krashes; Bradford B Lowell; Alastair S Garfield
Journal:  Nat Neurosci       Date:  2016-02       Impact factor: 24.884

7.  A comparative study of the central effects of specific proopiomelancortin (POMC)-derived melanocortin peptides on food intake and body weight in pomc null mice.

Authors:  Y C Loraine Tung; Sarah J Piper; Debra Yeung; Stephen O'Rahilly; Anthony P Coll
Journal:  Endocrinology       Date:  2006-09-07       Impact factor: 4.736

8.  Mice lacking PC1/3 expression in POMC-expressing cells do not develop obesity.

Authors:  Manita Shakya; Surbhi Gahlot; Anne White; C Bruce Verchere; Malcolm J Low; Iris Lindberg
Journal:  Endocrinology       Date:  2021-03-10       Impact factor: 4.736

Review 9.  Melanocortin Signaling Connecting Systemic Metabolism With Mood Disorders.

Authors:  Francesca Copperi; Jung Dae Kim; Sabrina Diano
Journal:  Biol Psychiatry       Date:  2021-06-05       Impact factor: 12.810

10.  Engineering the melanocortin-4 receptor to control constitutive and ligand-mediated G(S) signaling in vivo.

Authors:  Supriya Srinivasan; Pamela Santiago; Cecile Lubrano; Christian Vaisse; Bruce R Conklin
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.